$ELVN 8-K SEC Filings

Filed On	Filing
14 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Accomplished biopharmaceutical executive with extensive experience in corporate strategy, finance and commercial readiness
05 Aug 2026	8-K: Results of Operations and Financial Condition
12 Jun 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
11 Jun 2026	8-K: Regulation FD Disclosure; Other Events
10 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
03 Mar 2026	8-K: Results of Operations and Financial Condition
07 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
11 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
12 Nov 2025	8-K: Results of Operations and Financial Condition
13 Aug 2025	8-K: Results of Operations and Financial Condition
25 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
16 Jun 2025	8-K: Entry into a Material Definitive Agreement; Other Events
13 Jun 2025	8-K: Regulation FD Disclosure; Other Events
14 May 2025	8-K: Results of Operations and Financial Condition
13 Mar 2025	8-K: Results of Operations and Financial Condition
13 Nov 2024	8-K: Results of Operations and Financial Condition
13 Aug 2024	8-K: Results of Operations and Financial Condition
18 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
14 May 2024	8-K: Results of Operations and Financial Condition

Comments